Bluebird Bio Profit Margin 2012-2021 | BLUE
Current and historical gross margin, operating margin and net profit margin for Bluebird Bio (BLUE) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Bluebird Bio net profit margin as of June 30, 2021 is -1675.98%.
|Bluebird Bio Annual Profit Margins
|Bluebird Bio Quarterly Profit Margins
||Medical - Biomedical and Genetics
Bluebird Bio, Inc. is a biotechnology company. It focuses on the development, manufacture and marketing of therapies for severe genetic disorders such as childhood cerebral adrenoleukodystrophy, neurodegenerative disorders and beta-thalassemia. The company operates in the U.S. and Europe. Bluebird Bio, Inc. is headquartered in Cambridge, Massachusetts.